Order Article Reprints

Shah VM, Dorrell C, Al-Fatease A, Allen-Petersen BL, Woo Y, Bortnyak Y, Gheewala R, Sheppard BC, Sears RC, Alani AW. Microfluidics Formulated Liposomes of Hypoxia Activated Prodrug for Treatment of Pancreatic Cancer. Pharmaceutics. 2022; 14(4):713. https://doi.org/10.3390/pharmaceutics14040713

Shah, Vidhi M., Craig Dorrell, Adel Al-Fatease, Brittany L. Allen-Petersen, Yeonhee Woo, Yuliya Bortnyak, Rohi Gheewala, Brett C. Sheppard, Rosalie C. Sears, and Adam WG. Alani. 2022. "Microfluidics Formulated Liposomes of Hypoxia Activated Prodrug for Treatment of Pancreatic Cancer" Pharmaceutics 14, no. 4: 713. https://doi.org/10.3390/pharmaceutics14040713

Shah, V. M., Dorrell, C., Al-Fatease, A., Allen-Petersen, B. L., Woo, Y., Bortnyak, Y., Gheewala, R., Sheppard, B. C., Sears, R. C., & Alani, A. W. (2022). Microfluidics Formulated Liposomes of Hypoxia Activated Prodrug for Treatment of Pancreatic Cancer. Pharmaceutics, 14(4), 713. https://doi.org/10.3390/pharmaceutics14040713